LTβR agonist treated tumours (with or without Treg depletion), developed extensive and dense TA-HEVs which permeated into deeper parts of the tumour as compared to Treg depletion alone. LTβR agonist treated tumours did not have significantly more TILs or better control of tumour growth. Here, LTBR is linked to neoplasm.